logo
[breadcrumb_custom]

Category: Uncategorized
Uncategorized

Itron, Inc (ITRI) stock: In Limelight?

Itron, Inc. (NASDAQ: ITRI), a developer and manufacturer of smart infrastructure technology, released its first-quarter results. Itron was able to demonstrate the value of its solutions despite supply chain challenges and decreased revenue. Itron’s total revenue dropped 9% to $475 million in the third quarter (-6 percent excluding foreign exchange). Component shortages and supply chain issues have harmed Itron’s operations, preventing the company from satisfying all of its customers’ demands. Profits were also down against this backdrop. It was $1 million, or $0.02 per diluted share, versus $13 million and $0.3 the previous year. The order book (backlog) increased to

Why is Sanofi (SNY) up 13.36% from the day 1 this year?

For the readers interested in the stock health of Sanofi (SNY). It is currently valued at $52.69. When the transactions were called off in the previous session, Stock hit the highs of $53.18, after setting-off with the price of $52.78. Company’s stock value dipped to $52.49 during the trading on the day. When the trading was stopped its value was $52.87.Recently in News on February 18, 2022, Update on ongoing Dupixent® (dupilumab) chronic spontaneous urticaria Phase 3 program. Update on ongoing Dupixent® (dupilumab) chronic spontaneous urticaria Phase 3 program. You can read further details here Sanofi had a pretty favorable

Investchronicle.com is an Economic news website, which offers broad information about the Stock markets and Equities. The major emphasis of this platform is to present, the most practical recommendation for public and private capital sharing, both in the form of updates and detailed analysis.
Facebook-f Twitter Google-plus-g Pinterest

Quick Links

Categories

©Fueled By Smart TechOne